New insights into signalling-pathway alterations in rhabdomyosarcoma.
New insights into signalling-pathway alterations in rhabdomyosarcoma.
复制标题
DOI:
10.1038/bjc.2014.471
复制
发表时间:
2015-01-20
影响因子:
8.8
通讯作者:
Davie, J. K.
中科院分区:
文献类型:
--
作者:
Zhu, B.;Davie, J. K.
Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children and young adults. Several recent studies have shed new light on the alterations in signalling pathways and the downstream effects of these pathway alterations in RMS. Many of these effects converge on the fibroblast growth factor and insulin-like growth-factor pathways. These new findings improve the current understanding of RMS, thus offering novel potential therapeutic targets and strategies that may improve the outcome for patients with RMS.
登录
查看更多内容
影响因子:
4.5
作者:
Kikuchi K;Hettmer S;Aslam MI;Michalek JE;Laub W;Wilky BA;Loeb DM;Rubin BP;Wagers AJ;Keller C
通讯作者:
Keller C
影响因子:
45.3
作者:
Maki, Robert G.
通讯作者:
Maki, Robert G.
影响因子:
4.9
作者:
Marshall AD;Grosveld GC
通讯作者:
Grosveld GC
影响因子:
8
作者:
Ciarapica, R.;De Salvo, M.;Rota, R.
通讯作者:
Rota, R.
影响因子:
3.3
作者:
Vance KW;Shaw HM;Rodriguez M;Ott S;Goding CR
通讯作者:
Goding CR